Against a fairly bleak outlook for the UK economy, Jeremy Hunt’s latest budget as UK Chancellor of the Exchequer contained a number of measures that have been well receive
A just-published report on the UK's life sciences sector "ought to ring alarm bells across government," according to the Association of the British Pharmaceutical Industry (ABPI).<
Groups representing the biopharma industry have welcomed an increase in health-specific R&D to £5 billion in the UK autumn budget, despite a longer timeline for reaching the target of £
The UK's long-awaited Life Sciences Vision strategy has been published, setting out the government's stall as it tries to deliver on its promise to keep the country at the forefront of the
Problems at a contract manufacturing organisation have scuppered Eli Lilly’s hopes of a timely FDA approval for lebrikizumab, its IL-13 inhibitor for the treatment of atop
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho